Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trials. - Mayer-Hamblett N; Kerper NR; Clancy JP; Davies JC; Taylor-Cousar JL; Donaldson SH; Bell SC; Jain R; Simmonds NJ; Mall MA; Goss CH; Rayment JH; et al. (The Lancet. Respiratory medicine, 2025)